Pfizer - New York, NY
posted 5 days ago
The Director, HTA, Value & Evidence (HV&E) - Breast Cancer at Pfizer will play a crucial role in supporting the strategic goals of the Oncology Division by ensuring optimal patient access to breast cancer medicines, particularly Atirmociclib. This position involves developing and executing a global evidence generation strategy, overseeing health economics and outcomes research (HEOR), and collaborating with cross-functional teams to demonstrate the value of Pfizer's breast cancer portfolio. The role is integral to achieving business objectives on a global scale and fostering innovation within the organization.